James Strachan (@j_strachan_edit) 's Twitter Profile
James Strachan

@j_strachan_edit

Editor, The Analytical Scientist (@tAnaSci)

ID: 3880809747

calendar_today06-10-2015 13:27:39

1,1K Tweet

492 Followers

59 Following

Wellcome Sanger Institute (@sangerinstitute) 's Twitter Profile Photo

The #COVID19 pandemic has highlighted the growing influence of #WomenInScience. In @TheTimes, Director of COVID-19 Genomics UK (COG-UK) Consortium Sharon Peacock was listed among those “staging a quiet revolution” 🧪👩🏻‍🔬🔬🦠 #IWD2021 #InternationalWomensDay thetimes.co.uk/article/the-wo…

The Medicine Maker (@medicine_maker) 's Twitter Profile Photo

Our Cell + Gene Curator James Strachan introduces Walter Isaacson’s new book, The Code Breaker, which details Jennifer Doudna's remarkable personal story, as well as discussing the future implications for gene editing us4.campaign-archive.com/?u=49d1a796260…

Conexiant Europe (@conexianteurope) 's Twitter Profile Photo

We're on the lookout for an Associate Editor to join our ever-growing editorial team! Sound like your cup of tea ☕ ? Click the link below to find out more! bit.ly/38KwfgX

We're on the lookout for an Associate Editor to join our ever-growing editorial team!

Sound like your cup of tea ☕ ? 

Click the link below to find out more!
bit.ly/38KwfgX
Michael Retchin (@michaelretchin) 's Twitter Profile Photo

Science Newsletter #9 Cell + Gene Curator A weekly email on major advances and business updates across the world of cell and gene therapy. Edited by James Strachan. Subscribe and check out recent issues below. 👇 texerenewsletters.com/cellandgene

Jayasree Iyer (@jayasreekiyer) 's Twitter Profile Photo

Our new #paediatric analysis shows gaps in ensuring new products are accessible/affordable in markets where needed. Nearly 45% of late-stage paediatric treatments are not supported by #access plans. Raj Panjabi M.D. Michelle Mitchell Martina Penazzato Chewe Luo More:accesstomedicinefoundation.org/publications/c…

Our new #paediatric analysis shows gaps in ensuring new products are accessible/affordable in markets where needed. Nearly 45% of late-stage paediatric treatments are not supported by #access plans. <a href="/rajpanjabi/">Raj Panjabi M.D.</a> <a href="/Michelle_CRUK/">Michelle Mitchell</a> <a href="/penazzatom1/">Martina Penazzato</a> <a href="/LuoChewe/">Chewe Luo</a> 

More:accesstomedicinefoundation.org/publications/c…
Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 (@bllphd) 's Twitter Profile Photo

What can the advanced therapy sector learn from #COVID19 #vaccine development? We ask winners of The Medicine Maker 2021 Power List. #celltherapy #genetherapy The Medicine Maker ISCT themedicinemaker.com/business-regul…

Rick Yost (@dryost1) 's Twitter Profile Photo

James Strachan A wonderful example of this is the work of David Millington and Don Chace to develop newborn screening methods that are used to check nearly every new baby in the developed world for inherited diseases!